Gene · 1540
Papers3,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Familiar cylindromatosis in a Colombian family caused by a mutation in CYLD. | Ecancermedicalscience | 2024 | 39430072 | PubTator, text mining | PubMed |
| Case report: Multiple facial trichoepitheliomas caused by p.Val835SerfsTer52 variant of CYLD gene. | Front Med (Lausanne) | 2024 | 39403278 | PubTator, text mining | PubMed |
| The overlooked impact of cadmium on the progression of chronic hepatitis and the onset of renal failure in advanced cirrhosis. | J Trace Elem Med Biol | 2024 | 39395285 | PubTator, text mining | PubMed |
| CYLD Maintains Retinal Homeostasis by Deubiquitinating ENKD1 and Promoting the Phagocytosis of Photoreceptor Outer Segments. | Adv Sci (Weinh) | 2024 | 39373352 | PubTator, text mining | PubMed |
| Novel CYLD pathogenic variant associated with multiple cylindromas of the scalp-A case report. | Skin Health Dis | 2024 | 39355720 | PubTator, text mining | PubMed |
| Exploring and validating the necroptotic gene regulation and related lncRNA mechanisms in colon adenocarcinoma based on multi-dimensional data. | Sci Rep | 2024 | 39333335 | PubTator, text mining | PubMed |
| Cylindromatosis lysine 63 deubiquitinase (CYLD) suppress TLR3-mediated CCL5 expression in human renal proximal tubular epithelial cells. | Mol Biol Rep | 2024 | 39259342 | PubTator, text mining | PubMed |
| Genomic insights into molecular profiling of thymic carcinoma: a narrative review. | Mediastinum | 2024 | 39161584 | PubTator, text mining | PubMed |
| Influenza A virus infection activates caspase-8 to enhance innate antiviral immunity by cleaving CYLD and blocking TAK1 and RIG-I deubiquitination. | Cell Mol Life Sci | 2024 | 39158695 | PubTator, text mining | PubMed |
| Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia. | Mov Disord | 2024 | 39149795 | PubTator, text mining | PubMed |
| CYLD/HDAC6 signaling regulates the interplay between epithelial-mesenchymal transition and ciliary homeostasis during pulmonary fibrosis. | Cell Death Dis | 2024 | 39122680 | PubTator, text mining | PubMed |
| Cyld restrains the hyperactivation of synovial fibroblasts in inflammatory arthritis by regulating the TAK1/IKK2 signaling axis. | Cell Death Dis | 2024 | 39122678 | PubTator, text mining | PubMed |
| Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer. | Front Biosci (Landmark Ed) | 2024 | 39082359 | PubTator, text mining | PubMed |
| Grading Challenges and Prognostic Insights in Chromophobe Renal Cell Carcinoma: A Retrospective Study of 72 Patients. | Medicina (Kaunas) | 2024 | 38929613 | PubTator, text mining | PubMed |
| Lysine-63-linked polyubiquitination: a principal target of cadmium carcinogenesis. | Toxicol Res | 2024 | 38911543 | PubTator, text mining | PubMed |
| A computational approach for structural and functional analyses of disease-associated mutations in the human CYLD gene. | Genomics Inform | 2024 | 38907316 | PubTator, text mining | PubMed |
| Genetic and clinical landscape of Chinese frontotemporal dementia: dominance of TBK1 and OPTN mutations. | Alzheimers Res Ther | 2024 | 38872230 | PubTator, text mining | PubMed |
| MALT1 substrate cleavage: what is it good for? | Front Immunol | 2024 | 38863711 | PubTator, text mining | PubMed |
| Removal and assessment of cadmium contamination based on the toxic responds of a soil ciliate Colpoda sp. | J Hazard Mater | 2024 | 38823099 | PubTator, text mining | PubMed |
| A20 promoted the phagocytosis of lymphoma cells by dendritic cells from activated B-cell-like non-Hodgkin lymphoma. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38814241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1540/papers?page=8